Filana Therapeutics (FRA:PX91) Institutional Ownership: 8.85% (As of Aug. 03, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:PX91 Filana Therapeutics Inc FRA:PX91
26 GF Score
Price €0.82
! 1 Warning Sign
View Full Analysis

What is Filana Therapeutics Institutional Ownership?

Filana Therapeutics FRA:PX91 +10.05% 26 Institutional Ownership is 8.85% as of Aug. 03, 2026. GuruFocus rates FRA:PX91 with a GF Score™ of 26/100. The stock has 1 warning sign investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Filana Therapeutics's institutional ownership is 8.85%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Filana Therapeutics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Filana Therapeutics's Float Percentage Of Total Shares Outstanding is 97.95%.

Filana Therapeutics Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Filana Therapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Filana Therapeutics Institutional Ownership Chart

Filana Therapeutics Historical Data

The historical data trend for Filana Therapeutics can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 9.49 9.66 9.94 9.52 9.39 9.74 9.42 9.36 8.91 8.85
FRA:PX91
26GF Score
Filana Therapeutics Inc FRA:PX91
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Filana Therapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 8.85% mean?
Filana Therapeutics (FRA:PX91) has a Institutional Ownership of 8.85% as of Aug. 03, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Filana Therapeutics and its competitors.
Is Filana Therapeutics' Institutional Ownership too high?
Filana Therapeutics' current Institutional Ownership is 8.85%. Overall, Filana Therapeutics has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Filana Therapeutics' Institutional Ownership compare to INMB and DYAI?
Filana Therapeutics' Institutional Ownership of 8.85% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Filana Therapeutics and its competitors. Filana Therapeutics's current Institutional Ownership is 8.85%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Filana Therapeutics stock overvalued right now?
Filana Therapeutics (FRA:PX91) has a current Institutional Ownership of 8.85%. The current Institutional Ownership is 8.85%. Filana Therapeutics' overall GF Score™ is 26/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Filana Therapeutics (FRA:PX91), the current Institutional Ownership is 8.85% as of Aug. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Filana Therapeutics Business Description

Other Exchanges FLNA:USAFLNA:Mexico
Address 6801 N. Capital of Texas Highway, Suite 300, Building 1, Austin, TX, USA, 78731
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.
26GF Score

Get the complete analysis for FRA:PX91

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.82
Price